The identification and application of biomarkers in basic and clinical research is almost a mandatory process in any productive pipeline of a pharmaceutical organisation. Validated biomarkers play a crucial role in the prediction of clinical outcome and support the translation from candidate discovery to successful clinical treatment.
A wealth of valuable biomarker-related information is available in the biomedical literature. However, the process of discovering and validating new biomarkers depends on the ability to extract insight from this resource effectively.
SciBite uses semantic enrichment to unlock the value of unstructured text and simplify the identification of new potential biomarker leads from scientific text.
To learn more, download the full use case.
SciBite CSO and Founder Lee Harland shares his views on why ontologies are relevant in a machine learning-centric world and are essential to help "clean up" scientific data in the Life Sciences industry.Read
What’s the most useful way to visualise an ontology? SciBite CTO James Malone gives his views on answering this commonly asked question regarding ontology visualisation techniques.Read
Get in touch with us to find out how we can transform your data
© SciBite Limited / Registered in England & Wales No. 07778456